Krebs Biochemicals & Industries Limited (KREBSBIO.NS)

INR 99.85

(1.11%)

Annual Balance Sheets

(In INR)
Breakdown 2024 2023 2022 2021 2020 2019
Total Assets 1.78 Billion 1.74 Billion 1.89 Billion 1.59 Billion 1.33 Billion 1.42 Billion
Total Current Assets 174.42 Million 160.6 Million 354.93 Million 214.17 Million 188.59 Million 309.76 Million
Cash And Short Term Investments 1.37 Million 3.71 Million 324 Thousand 10.77 Million 560 Thousand 171.75 Million
Cash and Cash Equivalents 1.37 Million 858 Thousand 324 Thousand 7.1 Million 560 Thousand 171.75 Million
Short Term Investments 30.12 Million 2.85 Million 2.1 Million 3.66 Million - -
Net Receivables 19.03 Million 5.25 Million 19.5 Million 2.99 Million 10.34 Million 36.82 Million
Inventory 97.96 Million 119.45 Million 255.62 Million 166 Million 149.95 Million 89.63 Million
Other Current Assets 56.05 Million 32.18 Million 79.48 Million 34.4 Million 27.73 Million 11.55 Million
Total Non-Current Assets 1.6 Billion 1.58 Billion 1.54 Billion 1.37 Billion 1.14 Billion 1.11 Billion
Net PPE 1.49 Billion 1.48 Billion 1.44 Billion 1.26 Billion 1.05 Billion 1 Billion
Good Will And Intangible Assets 25.03 Million 26.87 Million 28.7 Million 35.09 Million 37.69 Million 40.3 Million
Good Will - - - - - -
Intangible Assets 25.03 Million 26.87 Million 28.7 Million 35.09 Million 37.69 Million 40.3 Million
Long-Term Investments 25.4 Million 20.89 Million 20.88 Million 18.76 Million 373 Thousand 374 Thousand
Tax Assets 6.56 Million 2.85 Million 51.37 Million 3.66 Million -373 Thousand -374 Thousand
Other Non Current Assets 55.76 Million 51.46 Million -1000.00 56.96 Million 54.59 Million 66.39 Million
Other Assets - - - - - -
Total Liabilities 2.97 Billion 2.74 Billion 2.64 Billion 2.01 Billion 1.58 Billion 1.56 Billion
Total Current Liabilities 618.33 Million 491.04 Million 780.64 Million 481.92 Million 431.33 Million 548.61 Million
Account Payables 189.7 Million 152.8 Million 379.06 Million 207.76 Million 226.91 Million 214.62 Million
Tax Payables - - - - - -
Short Term Debt 99.29 Million 99.9 Million 101.69 Million 105.91 Million 7.06 Million 31.5 Million
Deferred Revenue - 115.4 Million 151.81 Million -105.91 Million 110.53 Million 274.79 Million
Other Current Liabilities 329.34 Million 122.92 Million 148.07 Million 274.15 Million 86.81 Million 27.69 Million
Total Non Current Liabilities 2.35 Billion 2.25 Billion 1.86 Billion 1.53 Billion 1.15 Billion 1.01 Billion
Long-Term Debt 1.83 Billion 1.73 Billion 479.3 Million 1 Billion 805.05 Million 909.61 Million
Deferred Revenue Non Current - - - - - -
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 520.57 Million 520.92 Million 1.38 Billion 532.14 Million 351.56 Million 108.3 Million
Other Liabilities - - - - - -
Total Equity -1.19 Billion -994.62 Million -750.93 Million -427.32 Million -249.96 Million -142.89 Million
Stock Holders Equity -1.19 Billion -994.62 Million -750.93 Million -427.32 Million -249.96 Million -142.89 Million
Common Stock 215.6 Million 215.6 Million 215.6 Million 196.2 Million 180 Million 166.3 Million
Retained Earnings -2.7 Billion -2.5 Billion -2.26 Billion -1.81 Billion -1.53 Billion -1.11 Billion
Accumulated other comprehensive income -1.4 Billion 110.5 Million 110.5 Million 152.21 Million -1.36 Billion -1.32 Billion
Common Stock Equity -1.19 Billion -994.62 Million -750.93 Million -427.32 Million -249.96 Million -142.89 Million
Capital Lease Obligation - 450 Million 450 Million 450 Million 450 Million 407.34 Million
Total Investments 25.4 Million 23.75 Million 22.98 Million 22.43 Million 373 Thousand 374 Thousand
Total Debt 1.93 Billion 1.83 Billion 580.99 Million 1 Billion 812.12 Million 941.12 Million
Net Debt 1.93 Billion 1.83 Billion 580.67 Million 998.35 Million 811.56 Million 769.36 Million

Balance Sheet Charts